Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data (SERAS_Home_RWD)
Clinical Study for the Validation of the Medical Device Mjn-SERAS for the Detection and Prediction of Epileptic Seizures in Individuals from 12 to 65 Years, Suffering from Drug-resistant Epilepsy During Their Day-to-day Activity, to Find Out the Impact of the Digital Solution in the Quality of Life in a Normalised Environment and Provide Valuable Information from Real-World Data.
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
A observational or N/A phase clinical study on Epilepsy (treatment Refractory) and Quality of Life, this trial is actively recruiting participants. The trial is conducted by Clinica Universidad de Navarra, Universidad de Navarra and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Nov 2024 — Present [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jun 2023 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
May 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Clinica Universidad de Navarra, Universidad de Navarra
- Clínica Corachan
- Diakonie Kork
- MJN Neuroserveis, S.L
- Oxford University Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .